CII Prescription Regulations: What Cannot Be Changed and Multiple Prescription Rules
Items That Cannot Be Changed on a CII Prescription
On a Schedule II (CII) controlled substance prescription, the following items cannot be changed: Date issued, Patient Name, Drug Name, and Prescriber Signature. These are considered core elements that define the prescription's validity and authenticity under federal DEA regulations.
Unchangeable Elements:
- Date issued - Must reflect the actual date written
- Patient Name - Patient identity is fixed
- Drug Name - The specific controlled substance cannot be altered
- Prescriber Signature - Authentication cannot be modified
What CAN Be Changed:
- Directions - Under certain circumstances and with proper documentation, directions for use may be clarified or modified by the pharmacist in consultation with the prescriber, though this varies by state law
Important Caveat: Federal law prohibits verbal orders for CII prescriptions except to hold or stop administration. All new orders or changes must be made in writing 1. This strict requirement exists because CII substances have the highest potential for abuse among prescribable controlled substances.
Correct Statements About Multiple CII Prescription Law
The three correct statements regarding multiple CII prescription law are:
- Each prescription must be dated with the actual date they were written and not post-dated
- Each prescription must contain written instructions indicating the earliest date the prescription can be filled
- The total quantity prescribed across all prescriptions cannot exceed a 90-day supply when using the multiple CII prescription rule
Key Regulatory Points:
Dating Requirements: Each prescription in a multiple prescription series must bear the actual date it was written by the prescriber. Post-dating (writing a future date on the prescription at the time of creation) is prohibited under federal DEA regulations. This ensures proper documentation and prevents stockpiling of controlled substances.
Fill Date Instructions: The prescriber must explicitly indicate on each prescription the earliest date it may be filled. This allows for sequential dispensing while maintaining control over the supply timeline. This instruction must be written clearly on each individual prescription.
90-Day Supply Limit: Federal regulations cap the total quantity across all prescriptions in a multiple prescription scenario at a 90-day supply. This limitation balances patient access with abuse prevention measures.
Common Misconceptions:
Multiple prescriptions CANNOT be written on one prescription blank - Each prescription must be on a separate form, even though they are for the same schedule of controlled substance. This maintains clear documentation and tracking for each dispensing event.
There IS a limit on total quantity - The statement suggesting no limit exists is incorrect. The 90-day supply maximum is a firm federal requirement for multiple CII prescriptions.
Clinical Application:
This multiple prescription approach is typically used for patients requiring ongoing CII therapy (such as chronic pain management) where monthly office visits would be burdensome. The prescriber writes up to three separate prescriptions at one visit, each dated with the actual visit date, but with staggered "do not fill before" dates (e.g., 30 days apart), not exceeding 90 days total supply.